Accessibility Menu
 
Entera Bio logo

Entera Bio

(NASDAQ) ENTX

Current Price$1.34
Market Cap$63.50M
Since IPO (2018)-79%
5 Year-55%
1 Year-33%
1 Month+17%

Entera Bio Financials at a Glance

Market Cap

$63.50M

Revenue (TTM)

$0.00

Net Income (TTM)

$12.38M

EPS (TTM)

$-0.26

P/E Ratio

-4.90

Dividend

$0.00

Beta (Volatility)

0.52 (Low)

Price

$1.34

Volume

100,401

Open

$1.28

Previous Close

$1.32

Daily Range

$1.26 - $1.36

52-Week Range

$0.91 - $3.22

ENTX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Entera Bio

Industry

Biotechnology

Employees

22

CEO

Miranda J. Toledano, MBA

Headquarters

Jerusalem, 9112002, IL

ENTX Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-82%

Return on Capital

-1%

Return on Assets

-41%

Earnings Yield

-20.41%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$63.50M

Shares Outstanding

49.23M

Volume

100.40K

Avg. Volume

171.87K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$11.53M

EBITDA

$11.50M

Operating Cash Flow

$7.37M

Capital Expenditure

$107.00K

Free Cash Flow

$7.48M

Cash & ST Invst.

$7.11M

Total Debt

$490.00K

Entera Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$7.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$63.50M

N/A

Market Cap/Employee

$3.53M

N/A

Employees

18

N/A

Net Income

$3.50M

-36.5%

EBITDA

$3.53M

-38.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$3.69M

-70.1%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$263.00K

+415.7%

Short Term Debt

$185.00K

+9.5%

Return on Assets

-40.88%

N/A

Return on Invested Capital

-1.08%

N/A

Free Cash Flow

$3.09M

-118.8%

Operating Cash Flow

$3.09M

-120.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
INOInovio Pharmaceuticals, Inc.
$1.36+1.49%
MCRBSeres Therapeutics, Inc.
$8.03+3.48%
SEERSeer, Inc.
$1.75-1.13%
ANIXAnixa Biosciences, Inc.
$2.89-0.34%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$11.21+0.27%
FFord Motor Company
$14.48+0.07%
AIIORobo.ai
$5.64+1.16%
NOKNokia
$14.46-0.02%

Questions About ENTX

What is the current price of Entera Bio?

Entera Bio is trading at $1.32 per share.

What is the 52-week range for Entera Bio?

Over the past 52 weeks, Entera Bio has traded between $0.91 and $3.22.

How much debt does Entera Bio have?

As of the most recent reporting period, Entera Bio reported total debt of $448,000.

How much cash does Entera Bio have on hand?

Entera Bio reported $11.93M in cash and cash equivalents in its most recent financial results.

What is Entera Bio’s dividend yield?

Entera Bio does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.